Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Grigg

Showing results (141-150 of 180) with videos related to

Pageof 18
Sort By:
Annals of Hematology|November 8, 2006
The hyper-CVAD-rituximab chemotherapy programme followed by high-dose busulfan, melphalan and autologous stem cell transplantation produces excellent event-free survival in patients with previously untreated mantle cell lymphomaD S Ritchie, J F Seymour, A P Grigg, et al.
The Journal of Clinical Endocrinology and Metabolism|July 13, 2006
Pamidronate reduces bone loss after allogeneic stem cell transplantationA P Grigg, P Shuttleworth, J Reynolds, et al.
Leukemia & Lymphoma|December 29, 2004
Prognostic features for response and survival in elderly patients with de novo acute myeloid leukemia treated with mitoxantrone and intermediate dose cytarabineA P Grigg, J Reynolds, A McQuillan, et al.
Leukemia & Lymphoma|July 16, 2005
Autografting followed by rituximab for chemosensitive mantle cell lymphoma: a pilot study and literature reviewA P Grigg, J Bashford, J F Seymour, et al.
Medicine|August 15, 2020
Maternal bacteria to correct abnormal gut microbiota in babies born by C-sectionÉadaoin M Butler, Valentina Chiavaroli, José G B Derraik, et al.
Leukemia|July 16, 2016
The clinical significance of ABCB1 overexpression in predicting outcome of CML patients undergoing first-line imatinib treatmentL N Eadie, P Dang, V A Saunders, et al.
Thrombosis Research|August 6, 2016
The tyrosine kinase inhibitor, nilotinib potentiates a prothrombotic stateNaif Alhawiti, Kate L Burbury, Faith A Kwa, et al.
Internal Medicine Journal|July 1, 2008
Antifungal prophylaxis in adult stem cell transplantation and haematological malignancyM A Slavin, C H Heath, K A Thursky, et al.
Leukemia & Lymphoma|March 12, 2010
Phase II study of autologous stem cell transplant using busulfan-melphalan chemotherapy-only conditioning followed by interferon for relapsed poor prognosis follicular non-Hodgkin lymphomaAndrew P Grigg, Janey Stone, Alvin D Milner, et al.
Internal Medicine Journal|November 10, 2018
Recommendations for the use of pegylated interferon-α in the treatment of classical myeloproliferative neoplasmsCecily J Forsyth, Wai-Hoong Chan, Andrew P Grigg, et al.
Pageof 18

Showing results (141-150 of 180) with videos related to

Sort By:
Pageof 18
Annals of Hematology|November 8, 2006
The hyper-CVAD-rituximab chemotherapy programme followed by high-dose busulfan, melphalan and autologous stem cell transplantation produces excellent event-free survival in patients with previously untreated mantle cell lymphomaD S Ritchie, J F Seymour, A P Grigg, et al.
The Journal of Clinical Endocrinology and Metabolism|July 13, 2006
Pamidronate reduces bone loss after allogeneic stem cell transplantationA P Grigg, P Shuttleworth, J Reynolds, et al.
Leukemia & Lymphoma|December 29, 2004
Prognostic features for response and survival in elderly patients with de novo acute myeloid leukemia treated with mitoxantrone and intermediate dose cytarabineA P Grigg, J Reynolds, A McQuillan, et al.
Leukemia & Lymphoma|July 16, 2005
Autografting followed by rituximab for chemosensitive mantle cell lymphoma: a pilot study and literature reviewA P Grigg, J Bashford, J F Seymour, et al.
Medicine|August 15, 2020
Maternal bacteria to correct abnormal gut microbiota in babies born by C-sectionÉadaoin M Butler, Valentina Chiavaroli, José G B Derraik, et al.
Leukemia|July 16, 2016
The clinical significance of ABCB1 overexpression in predicting outcome of CML patients undergoing first-line imatinib treatmentL N Eadie, P Dang, V A Saunders, et al.
Thrombosis Research|August 6, 2016
The tyrosine kinase inhibitor, nilotinib potentiates a prothrombotic stateNaif Alhawiti, Kate L Burbury, Faith A Kwa, et al.
Internal Medicine Journal|July 1, 2008
Antifungal prophylaxis in adult stem cell transplantation and haematological malignancyM A Slavin, C H Heath, K A Thursky, et al.
Leukemia & Lymphoma|March 12, 2010
Phase II study of autologous stem cell transplant using busulfan-melphalan chemotherapy-only conditioning followed by interferon for relapsed poor prognosis follicular non-Hodgkin lymphomaAndrew P Grigg, Janey Stone, Alvin D Milner, et al.
Internal Medicine Journal|November 10, 2018
Recommendations for the use of pegylated interferon-α in the treatment of classical myeloproliferative neoplasmsCecily J Forsyth, Wai-Hoong Chan, Andrew P Grigg, et al.
Pageof 18